<DOC>
	<DOCNO>NCT00043849</DOCNO>
	<brief_summary>The primary aim study determine safety efficacy quetiapine ( Seroquel ) treatment psychosis and/or agitation patient primary dementia complicate coexistent parkinsonism , patient Parkinson 's disease dementia [ PDD ] episodes agitation psychosis . The secondary aim determine safety tolerability , particularly influence parkinsonism , quetiapine use treat psychosis and/or agitation patient dementia complicate coexistent parkinsonism .</brief_summary>
	<brief_title>Treatment Agitation/Psychosis Dementia/Parkinsonism ( TAP/DAP )</brief_title>
	<detailed_description>Psychosis agitation often occur course dementia major source patient disability caregiver stress . For common situation extrapyramidal ( parkinsonian ) motor dysfunction accompanies dementia , therapeutic dilemma since frequently use drug treat behavioral problem , neuroleptic antipsychotic , worsen parkinsonism associate severe extrapyramidal reaction type dementia . To date , efficacy tolerability promise alternative medication class treat psychosis agitation , namely atypical antipsychotic , test patient primary dementia select coexist parkinsonism . This multicenter double-blind , control clinical trial 60 subject primary dementia ( probable Alzheimer 's disease [ AD ] probable dementia Lewy body [ DLB ] ) coexist parkinsonism , Parkinson 's disease dementia [ PDD ] randomize 1 2 treatment group : ( 1 ) quetiapine ( QUET ) ; atypical antipsychotic favorable extrapyramidal side effect profile ) , ( 2 ) placebo . Each subject participate trial 10 week systematic rating behavior , motor function , cognition , adverse event outcomes occur baseline 6 10 week assign treatment .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Fluent English Spanish . Presence dementia define Diagnostic Statistical Manual Psychiatry , 4th ed . ( DSMIV ) American Psychiatric Association . 1994 . Meets NINDS/ADRDA diagnostic criterion probable Alzheimer 's disease [ AD ] Consortium diagnostic criterion probable dementia Lewy body [ DLB ] diagnostic criterion Parkinson 's disease dementia [ PDD ] . Presence psychosis and/or agitation interfere daily activity : ) psychosis , b ) hallucination , c ) delusion , ) agitation . Presence 2 follow extrapyramidal motor feature : ) rest tremor , b ) bradykinesia , c ) limb rigidity , ) shuffling , shortstepped gait . Sum rating rest tremor , bradykinesia , rigidity gait item Unified Parkinson 's Disease Rating Scale ( UPDRS ) motor examination component must great equal 2 . Brief Psychiatric Rating Scale ( BPRS ) score great equal 12 . Informed consent participant appropriate proxy . Spouse/caregiver willing able accompany subject clinic visit . A stable dosage nonexcluded medication least 2 week prior Screening Visit . Is stable medical condition least 4 week prior Screening Visit . Physically acceptable study confirm medical history , physical exam clinical laboratory test . Must able ingest oral medication . Supervision must available administration study medication . Taking marketed cholinesterase inhibitor ( donepezil [ Aricept ] , rivastigmine [ Exelon ] , galantamine [ Reminyl ] , tacrine [ Cognex ] , and/or memantine dose unchanged least 2 week prior screen visit . Participants may reside home supervise care set , nurse home . Mini Mental Status Examination Score &lt; 8 . Use follow 3 week prior screen visit : ( ) neuroleptic atypical antipsychotic medication ; ( b ) anticholinergic drug , amantadine treatment parkinsonism [ treatment levodopa ( Sinemet , Sinemet CR ) dopamine agonist , selegiline entacapone allow ] . A history severe adverse reaction antipsychotic medication . A serious medical illness would preclude safe administration quetiapine , include active cancer . Skin tumor malignant melanoma exclusionary . Patients stable prostate cancer may include discretion Program Director . Current evidence history last 2 year epilepsy , focal brain lesion , head injury loss consciousness and/or immediate confusion injury . Known pregnancy . Excluded Medications During Study : Any classical neuroleptic antipsychotic , haloperidol ( Haldol ) . Any atypical antipsychotic , risperidone ( Risperidal ) , quetiapine ( Seroquel ) , ziprasidone ( Geodon ) , olanzapine ( Zyprexa ) clozapine ( Clozaril ) . Any anxiolytic lorazepam ( Ativan ) , describe . This include clonazepam ( Klonopin ) , diazepam ( Valium ) , oxazepam ( Serax ) , clorazepate ( Tranxene ) , buspirone ( Buspar ) hydroxyzine ( Vistaril ) . Any hypnotic lorazepam ( Ativan ) , describe . This include estazolam ( Prosom ) , flurazepam ( Dalmane ) , quazepam ( Doral ) , temazepam ( Restoril ) , triazolam ( Halcion ) , diphenhydramine ( Benadryl ) , doxylamine ( Unisom ) , zolpidem ( Ambien ) , zaleplon ( Sonata ) chloral hydrate .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Psychosis</keyword>
	<keyword>Agitation , Psychomotor</keyword>
</DOC>